No Data
No Data
No Data
No Data
No Data
Express News | Larimar Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $25 Price Target
Moomoo 24/7Apr 3 09:39 ET
Larimar Therapeutics Initiated at Outperform by Leerink Partners
Larimar Therapeutics Initiated at Outperform by Leerink Partners
Dow JonesApr 3 09:28 ET
Express News | Leerink Partners Initiates Coverage On Larimar Therapeutics With Outperform Rating, Announces Price Target of $25
Moomoo 24/7Apr 3 09:18 ET
Buy Rating Justified: Larimar Therapeutics' Advancements Towards FDA Approval for FA Drug Nomlabofusp
TipRanksMar 15 16:15 ET
Recap: Larimar Therapeutics Q4 Earnings
Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsLarimar Therapeutics misse
BenzingaMar 14 17:15 ET
Express News | Larimar Therapeutics Q4 EPS $(0.30), Cash Position $86.8M
Moomoo 24/7Mar 14 16:15 ET
Just Care BearsOP : Phase 2 I mean
No Data
No Data